Robert Carey, Director at Argos Therapeutics, holds 1.48M shares in Beyond Air (Ticker: XAIR), holds 74.60K shares in Sangamo Biosciences (Ticker: SGMO), holds 266.36K shares in Horizon Therapeutics (Ticker: HZNP). Most recently, Robert Carey Bought ― shares of Beyond Air on Oct 01, 2024 for an estimated value of 738.31K.
What is the percentage of profitable transactions made by Robert Carey?
The percentage of profitable transactions made by Robert Carey is 41%.
What is the average return per transaction made by Robert Carey?
The average return per transaction made by Robert Carey is -22.80%.
What stocks does Robert Carey hold?
Robert Carey holds: ARGSQ, SGMO, XAIR, HZNP stocks.
What was Robert Carey’s latest transaction?
Robert Carey latest transaction was an Informative Buy of $738.31K.
What was Robert Carey's most profitable transaction?
Robert Carey’s most profitable transaction was an Informative Buy of XAIR stock on August 26, 2020. The return on the trade was 76.10%.
What is Robert Carey's role in Argos Therapeutics?
Robert Carey's role in Argos Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.